NCT00615160 2021-10-06
PTK/ZK in Disseminated Malignant Melanoma
University Hospital Schleswig-Holstein
Phase 1/2 Terminated
Clinical Trials
8 trialsNCT00216047 2015-12-09
PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer
Hoosier Cancer Research Network
Phase 1/2 Terminated
NCT00185588 2014-09-15
Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer
Stanford University
Phase 1/2 Completed
NCT00293371 2012-10-11
Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer
University of California, San Francisco
Phase 1/2 Terminated
NCT00128700 2012-09-24
Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1/2 Completed
NCT00281125 2012-03-19
Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer
Nevada Cancer Institute
Phase 1/2 Terminated
NCT00088231 2012-01-20
PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT00171587 2009-11-19
Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer
Novartis
Phase 1/2 Completed